Camila LOPES RIBEIRO, Jair RODINI ENGRACIA FILHO, Tilde RODRIGUES FROES, Angelica INAJA JULIANI, Simone DOMIT GUERIOS, Daniella Matos DA SILVA

Abdominal ultrasonographic findings in dogs with mammary tumors: association with tumor characteristics and survival

Abdominal ultrasound is frequently performed as part of initial staging of canine mammary tumors. The aims of this studywere to describe abdominal ultrasonographic findings present at diagnosis of mammary tumors in dogs and to assess their value forassociations with histopathological results and treatment outcome. The medical records of 201 female dogs diagnosed with mammarytumors that had abdominal ultrasonography performed as part of their initial clinical evaluation were reviewed. Histopathologicaldiagnosis of malignant mammary tumors was obtained in most cases (86%; 172 cases). One hundred and fifty-seven animals (78%)had some ultrasonographic abnormality. A total of 338 ultrasonographic changes were identified, and the spleen was the organ with thehighest frequency of ultrasonographic changes (20%), followed by the uterus (18%) and the liver (16%). Abdominal ultrasonographyabnormalities were not associated with mammary tumor malignancy (OR = 1.7; P = 0.27). Ultrasonographic evidence of enlargedintraabdominal lymph nodes was associated with metastases in surface regional lymph nodes (P < 0.05). Dogs with regional metastasiswere more likely to present some abdominal ultrasonographic change (OR = 6.1; P = 0.04). Animals with ultrasonographic evidence ofintraabdominal lymph node enlargement presented shorter survival after mastectomy. Abdominal ultrasonographic abnormalities arecommon in dogs with mammary tumors and are not associated with malignancy. However, the presence of intraabdominal lymph nodeenlargement identified by ultrasound may be associated with regional metastasis and shorter survival rates.

PDF

___

1. Sorenmo K. Canine mammary gland tumors. Veterinary Clinics of North America: Small Animal Practice 2003; 33: 573-596. doi: 10.1016/S0195-5616(03)00020-2
2. Meuten DJ. Tumors in Domestic Animals. 5th ed. Ames, IA, USA: John Wiley & Sons; 2017.
3. Owen LN. TNM Classification of Tumors in Domestic Animals. 1st ed. Geneva, Switzerland: World Health Organization; 1980.
4. Otoni CC, Rahal SC, Vulcano LC, Ribeiro SM, Hette K et al. Survey radiography and computerized tomography imaging of the thorax in female dogs with mammary tumors. Acta Veterinaria Scandinavica 2010; 52: 20. doi: 10.1186/1751-0147- 52-20
5. Sorenmo KU, Rasotto R, Zappulli V, Goldschmidt MH. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms. Veterinary Pathology 2011; 48 (1): 85-97. doi: 10.1177/0300985810389480
6. Clemente M, Pérez-Alenza MD, Peña L. Metastasis of canine inflammatory versus non-inflammatory mammary tumours. Journal of Comparative Pathology 2010; 143 (2-3): 157-163. doi: 10.1016/j.jcpa.2010.02.002
7. Sacornrattana O, Dervisis NG, McNiel EA. Abdominal ultrasonographic findings at diagnosis of osteosarcoma in dogs and association with treatment outcome. Veterinary and Comparative Oncology 2013; 11 (3): 199-207. doi: 10.1111/j.1476-5829.2011.00312.x
8. Bigio Marcello A, Gieger TL, Jiménez DA, Granger LA. Detection of comorbidities and synchronous primary tumours via thoracic radiography and abdominal ultrasonography and their influence on treatment outcome in dogs with soft tissue sarcomas, primary brain tumours and intranasal tumours. Veterinary and Comparative Oncology 2015; 13 (4): 433-442. doi: 10.1111/vco.12063
9. Warland J, Amores-Fuster I, Newbury W, Brearley M, Dobson J. The utility of staging in canine mast cell tumours. Veterinary and Comparative Oncology 2014; 12 (4): 287-298. doi: 10.1111/ vco.12012
10. Tong NM, Zwingenberger AL, Blair WH, Taylor SL, Chen RX et al. Effect of screening abdominal ultrasound examination on the decision to pursue advanced diagnostic tests and treatment in dogs with neurologic disease. Journal of Veterinary Internal Medicine 2015; 29 (3): 893-899. doi: 10.1111/jvim.12602
11. Secchi P, Pöppl AG, Ilha A, Kunert Filho HC, Lima FE et al. Prevalence, risk factors, and biochemical markers in dogs with ultrasound-diagnosed biliary sludge. Research in Veterinary Science 2012; 93 (3): 1185-1189. doi: 10.1016/j.rvsc.2012.03.009
12. Webb JA, Kirby GM, Nykamp SG, Gauthier MJ. Ultrasonographic and laboratory screening in clinically normal mature golden retriever dogs. Canadian Veterinary Journal 2012; 53 (6): 626-630.
13. Kristiansen VM, Nødtvedt A, Breen AM, Langeland M, Teige J et al. Effect of ovariohysterectomy at the time of tumor removal in dogs with benign mammary tumors and hyperplastic lesions: a randomized controlled clinical trial. Journal of Veterinary Internal Medicine 2013; 27 (4): 935-942. doi: 10.1111/ jvim.12110
14. Kristiansen VM, Peña L, Díez Córdova L, Illera JC, Skjerve E et al. Effect of ovariohysterectomy at the time of tumor removal in dogs with mammary carcinomas: a randomized controlled trial. Journal of Veterinary Internal Medicine 2016; 30 (1): 230- 234. doi: 10.1111/jvim.13812
15. De Bosschere H, Ducatelle R, Vermeirsch H, Simoens P, Coryn M. Estrogen-alpha and progesterone receptor expression in cystic endometrial hyperplasia and pyometra in the bitch. Animal Reproduction Science 2002; 70 (3-4): 251-259. doi: 10.1016/S0378-4320(02)00013-1
16. Lamp O, Honscha KU, Schweizer S, Heckmann A, Blaschzik S et al. The metastatic potential of canine mammary tumours can be assessed by mRNA expression analysis of connective tissue modulators. Veterinary and Comparative Oncology 2013; 11: 70-85. doi: 10.1111/j.1476-5829.2011.00303.x
17. Oliveira Filho JC, Kommers GD, Masuda EK, Marques BMFPP, Fighera RA et al. Estudo retrospectivo de 1.647 tumores mamários em cães. Pesquisa Veterinária Brasileira 2010; 30 (2): 177-185 (in Portuguese). doi: 10.1590/S0100- 736X2010000200014
18. Chang SC, Chang CC, Chang TJ, Wong ML. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002). Journal of the American Veterinary Medical Association 2005; 227 (10): 1625-1629. doi: 10.2460/javma.2005.227.1625
19. Sleeckx N, de Rooster H, Veldhuis Kroeze E, Van Ginneken C, Van Brantegem L. Canine mammary tumours, an overview. Reproduction in Domestic Animals 2011; 46 (6): 1112:1131. doi: 10.1111/j.1439-0531.2011.01816.x
20. de Araújo MR, Campos LC, Ferreira E, Cassali GD. Quantitation of the regional lymph node metastatic burden and prognosis in malignant mammary tumors of dogs. Journal of Veterinary Internal Medicine 2015; 29 (5): 1360-1367. doi: 10.1111/jvim.13576
21. Patsikas MN, Karayannopoulou M, Kaldrymidoy E, Papazoglou LG, Papadopoulou PL et al. The lymph drainage of the neoplastic mammary glands in the bitch: a lymphographic study. Anatomia, Histologia, Embryologia 2006; 35 (4): 228- 234. doi: 10.1111/j.1439-0264.2005.00664.x
22. Sorenmo KU, Kristiansen VM, Cofone MA, Shofer FS, Breen AM et al. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Veterinary and Comparative Oncology 2009; 7 (3): 162-172. doi: 10.1111/j.1476- 5829.2009.00184.x